In the first agreement of its kind, the NIA and the BBSRC are to jointly fund ageing research projects with a total value of £4 million.

There are signs the financing drought brought on by the credit crunch may be over for European biotechs as investors loosen the purse strings.

Merck Serono is to establish a global R&D centre in Beijing, investing more than €150 million over the next four years.